Medicare Enrolled
Dr. Nassir Azimi, M.D.
Cardiovascular Disease · La Mesa, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Azimi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Azimi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Azimi
Dr. Nassir Azimi is a cardiovascular disease specialist in La Mesa, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Azimi performed 23,612 Medicare services across 5,932 unique beneficiaries.
Between the years covered by Open Payments, Dr. Azimi received a total of $890,586 from 69 pharmaceutical and/or device companies across 1619 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Azimi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in CA
$890,586 industry payments
Medicare Practice Summary
Medicare Utilization ↗23,612
Medicare services
Top 1% in CA for cardiovascular disease
5,932
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,181 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Inclisiran injection (Leqvio) for cholesterol | 9,657 | $9 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,568 | $98 | $177 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,601 | $51 | $79 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
1,410 | $41 | $83 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,079 | $45 | $106 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
1,077 | $33 | $67 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,065 | $65 | $126 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
876 | $12 | $35 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
557 | $165 | $349 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
485 | $38 | $68 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
375 | $153 | $339 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
308 | $97 | $167 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
270 | $123 | $265 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
245 | $56 | $118 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
243 | $139 | $326 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
200 | $217 | $432 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
199 | $92 | $225 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
154 | $64 | $122 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
134 | $106 | $260 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
127 | $52 | $149 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
116 | $20 | $44 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
116 | $53 | $98 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
97 | $10 | $90 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
74 | $48 | $98 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
63 | $233 | $399 |
| Cardiac catheterization | 61 | $159 | $602 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
61 | $157 | $332 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
51 | $41 | $89 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
39 | $432 | $971 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
39 | $61 | $119 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
33 | $12 | $24 |
| Iliac or femoral artery angiography with cardiac catheterization An X-ray imaging procedure of the iliac or femoral arteries performed simultaneously with a cardiac catheterization or coronary angiography. The process includes positioning the catheter in the distal aorta. |
33 | $11 | $41 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 28 | $239 | $1,017 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
26 | $159 | $302 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
24 | $17 | $44 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
24 | $11 | $29 |
| Repair of left upper heart chamber with implant A surgical procedure to repair the left upper chamber of the heart using an implanted device, with review by a radiologist. |
19 | $616 | $1,242 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
18 | $20 | $48 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
17 | $10 | $27 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
16 | $6 | $14 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
14 | $18 | $32 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
13 | $50 | $83 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.1% high complexity
46.1% medium
50.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$890,586
Total received (2018-2024)
Avg $127,227/year across 7 years
Top 1% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
1,619
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$803,807 (90.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$55,655 (6.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$31,124 (3.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$99,071
2023
$148,573
2022
$151,159
2021
$69,869
2020
$62,969
2019
$170,067
2018
$188,878
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$36,269
Janssen Pharmaceuticals, Inc
$17,324
American Regent
$14,370
AstraZeneca Pharmaceuticals LP
$12,452
Esperion Therapeutics, Inc.
$11,484
Bayer Healthcare Pharmaceuticals Inc.
$4,038
Merck Sharp & Dohme LLC
$280
Edwards Lifesciences Corporation
$276
Boehringer Ingelheim Pharmaceuticals, Inc.
$253
GlaxoSmithKline, LLC.
$244
ABIOMED
$222
Lexicon Pharmaceuticals, Inc.
$221
Novartis Pharmaceuticals Corporation
$220
Novo Nordisk Inc
$211
Abbott Laboratories
$163
Penumbra, Inc.
$160
Amgen Inc.
$137
Gilead Sciences, Inc.
$125
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$119
Alnylam Pharmaceuticals Inc.
$70
BIOTRONIK INC.
$57
PFIZER INC.
$57
Boston Scientific Corporation
$53
SCPHARMACEUTICALS INC.
$52
SANOFI-AVENTIS U.S. LLC
$50
Inspire Medical Systems, Inc.
$38
Kiniksa Pharmaceuticals International, plc
$31
E.R. Squibb & Sons, L.L.C.
$28
Kestra Medical Technology Services, Inc.
$25
CVRx, Inc.
$24
Medtronic, Inc.
$20
Top 3 companies account for 68.6% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$464,309
Daiichi Sankyo Inc.
$195,068
AstraZeneca Pharmaceuticals LP
$61,232
Bayer Healthcare Pharmaceuticals Inc.
$35,382
Bayer HealthCare Pharmaceuticals Inc.
$32,270
Cardinal Health 200 LLC
$15,248
American Regent
$14,428
Esperion Therapeutics, Inc.
$12,093
Pharmacosmos Therapeutics Inc.
$11,711
CVRx, Inc.
$10,399
Novo Nordisk Inc
$7,976
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$6,602
Boston Scientific Corporation
$2,721
W. L. Gore & Associates, Inc.
$1,651
Novartis Pharmaceuticals Corporation
$1,322
Edwards Lifesciences Corporation
$1,311
Medtronic Vascular, Inc.
$1,243
Cardinal Health 200, LLC
$1,195
Philips Electronics North America Corporation
$1,183
Medtronic, Inc.
$1,042
Abbott Laboratories
$948
Boehringer Ingelheim Pharmaceuticals, Inc.
$940
Baylis Medical Company Inc
$793
Amgen Inc.
$728
Merck Sharp & Dohme LLC
$654
BIOTRONIK INC.
$615
SANOFI-AVENTIS U.S. LLC
$569
PFIZER INC.
$543
Kowa Pharmaceuticals America, Inc.
$542
E.R. Squibb & Sons, L.L.C.
$460
Lexicon Pharmaceuticals, Inc.
$454
La Jolla Pharmaceutical Company
$406
Actelion Pharmaceuticals US, Inc.
$374
ABIOMED
$355
Amarin Pharma Inc.
$330
Chiesi USA, Inc.
$295
Regeneron Healthcare Solutions, Inc.
$258
BOSTON SCIENTIFIC CORPORATION
$252
GlaxoSmithKline, LLC.
$244
United Therapeutics Corporation
$215
Penumbra, Inc.
$160
Alnylam Pharmaceuticals Inc.
$159
EKOS Corporation
$139
Biohaven Pharmaceuticals, Inc.
$133
Inari Medical, Inc.
$127
Gilead Sciences, Inc.
$125
Sunovion Pharmaceuticals Inc.
$125
Melinta Therapeutics, LLC
$125
GENZYME CORPORATION
$124
SCPHARMACEUTICALS INC.
$108
Acera Surgical, Inc.
$107
ZOLL Circulation Inc
$98
Otsuka America Pharmaceutical, Inc.
$90
Kiniksa Pharmaceuticals, Ltd.
$79
Merck Sharp & Dohme Corporation
$78
Janssen Scientific Affairs, LLC
$66
Kestra Medical Technology Services, Inc.
$63
Impulse Dynamics (USA) Inc.
$56
Itamar Medical Inc
$43
Allergan Inc.
$39
Inspire Medical Systems, Inc.
$38
Kiniksa Pharmaceuticals International, plc
$31
Baxter Healthcare
$24
Cardiovascular Systems Inc.
$21
Arbor Pharmaceuticals, Inc.
$18
Arrow International, Inc.
$14
Bardy Diagnostics, Inc.
$14
Lilly USA, LLC
$13
Bard Peripheral Vascular, Inc.
$11
Top 3 companies account for 80.9% of all-time payments
Associated products mentioned in payments ›
(6571) Eagle Eye · (6585) Omniwire · (9266) ELCA · (9267) AngioSculpt CV RX · AMVUTTRA · ANDEXXA · AREXVY · ATACAND · Acticor · Adempas · Amplia MRI · Arcalyst · Assure WCD · Azure · BIOMONITOR · BREZTRI · BRIDION · BRILINTA · BYSTOLIC · Barostim Neo System · BioMonitor · BioMonitor 2 · CAMZYOS · CARDIOMEMS · CLEVIPREX · COREVALVE EVOLUT R · CVX-300 · CardioMEMS HF System · Carnation Ambulatory Monitor · Catheter - Turnpike · Confirm Rx · CoreValve Evolut · DIAMONDBACK PERIPHERAL · DUPIXENT · Diamondback Coronary · EKOSONIC · ELIQUIS · ENTRESTO · ESPRIT · EVKEEZA · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EluNIR Radaforolimus Eluting Coronary Stent System · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · GIAPREZA · GORE CARDIOFORM Septal Occluder · Hillrom - Cardiac Ambulatory Monitor · IGT D Coronary · INJECTAFER · INSPIRE · INVOKANA · Image Guided Therapy Devices _ Coronary · Impella · Indigo System · Inpefa · JARDIANCE · JOT DX · KENGREAL · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · Kerendia · LEQVIO · LIVALO · LONHALA MAGNAIR · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MICRA · MITRACLIP · MONOFERRIC · MULTAQ · Micra · Mitra Clip system · Monoferric · MynxGrip Vascular Closure Device · NEXLETOL · NEXLIZET · NRG · NURTEC ODT · OFEV · ONPATTRO · OPDIVO · OPSUMIT · Optimizer · Orsiro · Ozempic · PK Papyrus · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Product in Development · Pulsar · RAILWAYTM · RESONATE · Repatha · Resolute · Restrata Wound Matrix · Reveal LINQ · Rybelsus · S · SAMSCA · SAPIEN 3 Ultra RESILIA · SYMPLICITY G3 · SYNERGY · Saxenda · TAGRISSO · TEZSPIRE · TherOx DS2 Console · UPTRAVI · VERQUVO · VYNDAMAX · VYNDAQEL · Vabomere · Vascepa · Veklury · VersaCross Access Solution · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WINREVAIR · WatchPAT · WatchPATONE · Wegovy · XARELTO · XIGDUO · Xience Sierra Coronary Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
239
Per 100K population
7.3
County median income
$102,285
Nearest hospital
GROSSMONT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Azimi is a clinical cardiology specialist, with above-average Medicare volume (top 1% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Azimi experienced with inclisiran injection (leqvio) for cholesterol?
Based on Medicare claims data, Dr. Azimi performed 9,657 inclisiran injection (leqvio) for cholesterol services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Azimi receive payments from pharmaceutical companies?
Yes. Dr. Azimi received a total of $890,586 from 69 companies across 1,619 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Azimi's costs compare to other cardiologists in La Mesa?
Dr. Azimi's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Azimi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in La Mesa
Browse cardiologists in La Mesa ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology